Drug recall
Tizanidine Hydrochloride Tablets, 2 mg, Rx only, Teva Pharmaceuticals, USA, Sellersville, PA 18960, NDC…
FDA recall event 34937 · Class II · Teva Pharmaceuticals
Key facts
| Event ID | 34937 |
|---|---|
| Recall numbers | D-229-6, D-230-6 |
| Recalling firm | Teva Pharmaceuticals |
| Product type | Drugs |
| Products | Tizanidine Hydrochloride Tablets, 2 mg, Rx only, Teva Pharmaceuticals, USA, Sellersville, PA 18960, NDC 0093-5163-51, Tizanidine Hydrocloride Tablets, 4 mg, Rx only, Teva Pharmaceuticals, USA, Sellersville, PA 18960, NDC 0093-5160-51 |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution Failure |
| Initiation date | Mar 20, 2006 |
| City | Sellersville |
| Country | United States |
At a glance
- 1–9 Products in this recall
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports